Question

Per the NCCN Guidelines ( ), because of Mrs. Turner's age ≥ 65 as well as a previous neutropenic episode, she would be a candidate to receive a GCSF. Her febrile neutropenic episode requiring hospitalization puts her at high risk for additional neutropenia.

a) Increase the chemotherapy dose
b) Administer additional antibiotics
c) Continue the current chemotherapy regimen
d) Administer GCSF (Granulocyte Colony-Stimulating Factor)

Answer 1

Mrs. Turner should receive Granulocyte Colony-Stimulating Factor (GCSF), as per NCCN Guidelines, due to her age and previous neutropenic episode, which puts her at high risk for further neutropenia. So, correct option is (d).

Step-by-step explanation:

Based on the NCCN Guidelines, due to Mrs. Turner's age (≥65 years) and a previous neutropenic episode, she would indeed be a candidate to receive Granulocyte Colony-Stimulating Factor (GCSF). Since her febrile neutropenic episode required hospitalization and places her at high risk for additional neutropenia, the correct action would be to administer GCSF rather than increasing the chemotherapy dose, adding additional antibiotics, or continuing with the current chemotherapy regimen without intervention.

GCSF is utilized to stimulate the production of white blood cells, particularly neutrophils, and can help patients recover quicker from neutropenia caused by chemotherapy.

GCSF is a synthetic form of a hormone that stimulates the production of granulocyte leukocytes, including neutrophils. By administering GCSF, it can help prevent additional neutropenia and decrease the risk of febrile neutropenic episodes requiring hospitalization.